The ACI: A Focus on Advanced Practitioners program is a CME certified course geared specifically for advanced practitioners using cancer immunotherapy in a clinical setting. This program will prepare you to better treat cancer patients using immunotherapy.
Webinar Faculty:
- Krista Rubin, MS, FNP-BC – Massachusetts General Hospital
The 2023 Advances in Cancer Immunotherapy™ series is jointly provided by Partners for Advancing Clinical Education (PACE) and SITC. The program brought to you in collaboration with the Association of Community Cancer Centers, Advanced Practitioner Society for Hematology and Oncology, and the Hematology/Oncology Pharmacy Association.
The 2023 Advances in Cancer Immunotherapy™ educational series is supported, in part, through independent medical education grants from AstraZeneca, Bristol Myers Squibb, Exelixis, Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD) and Novartis Pharmaceuticals Corporation. (as of 6/18/2023)